249 related articles for article (PubMed ID: 3106484)
21. Uncoupling of c-myc mRNA expression from G1 events in human T lymphocytes.
Friedrich B; Gullberg M; Lundgren E
Anticancer Res; 1988; 8(1):23-8. PubMed ID: 3128958
[TBL] [Abstract][Full Text] [Related]
22. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
Gogusev J; Barbey S; Nezelof C
Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
[TBL] [Abstract][Full Text] [Related]
23. The murine T cell line CT6 provides a novel bioassay for interleukin-7.
Willcocks JL; Hales A; Page TH; Foxwell BM
Eur J Immunol; 1993 Mar; 23(3):716-20. PubMed ID: 8449219
[TBL] [Abstract][Full Text] [Related]
24. Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines.
Nuñez G; London L; Hockenbery D; Alexander M; McKearn JP; Korsmeyer SJ
J Immunol; 1990 May; 144(9):3602-10. PubMed ID: 2184193
[TBL] [Abstract][Full Text] [Related]
25. Bombesin induction of c-fos and c-myc proto-oncogenes in Swiss 3T3 cells: significance for the mitogenic response.
Rozengurt E; Sinnett-Smith JW
J Cell Physiol; 1987 May; 131(2):218-25. PubMed ID: 3108267
[TBL] [Abstract][Full Text] [Related]
26. A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1.
Heikkila R; Schwab G; Wickstrom E; Loke SL; Pluznik DH; Watt R; Neckers LM
Nature; 1987 Jul 30-Aug 5; 328(6129):445-9. PubMed ID: 3302722
[TBL] [Abstract][Full Text] [Related]
27. c-myc and c-myb oncoproteins during induced maturation of myeloid and erythroid human leukemic cell lines.
Pedrazzoli P; Bains MA; Watson R; Fisher J; Hoy TG; Jacobs A
Cancer Res; 1989 Dec; 49(24 Pt 1):6911-6. PubMed ID: 2684403
[TBL] [Abstract][Full Text] [Related]
28. Effect of Na + flux inhibitors on induction of c-fos, c-myc, and ODC genes during cell cycle.
Panet R; Amir I; Snyder D; Zonenshein L; Atlan H; Laskov R; Panet A
J Cell Physiol; 1989 Jul; 140(1):161-8. PubMed ID: 2472417
[TBL] [Abstract][Full Text] [Related]
29. Insulin-like growth factor I induction of c-myc expression in bovine fibroblasts can be blocked by antecedent insulin receptor activation.
Conover CA; Bale LK
Exp Cell Res; 1998 Jan; 238(1):122-7. PubMed ID: 9457064
[TBL] [Abstract][Full Text] [Related]
30. Cellular oncogenes and lymphocyte activation.
Schneider-Schaulies J; Knauer R; Schimpl A; Wecker E
Behring Inst Mitt; 1987 Jun; (81):110-9. PubMed ID: 3115245
[TBL] [Abstract][Full Text] [Related]
31. Identification of AKT-regulated genes in inducible MERAkt cells.
Kuhn I; Bartholdi MF; Salamon H; Feldman RI; Roth RA; Johnson PH
Physiol Genomics; 2001 Dec; 7(2):105-14. PubMed ID: 11773597
[TBL] [Abstract][Full Text] [Related]
32. c-fos is a positive regulator of carcinogen enhancement of adenovirus transformation.
Su ZZ; Yemul S; Stein CA; Fisher PB
Oncogene; 1995 May; 10(10):2037-49. PubMed ID: 7761104
[TBL] [Abstract][Full Text] [Related]
33. Regulation of cell cycle duration by c-myc levels.
Karn J; Watson JV; Lowe AD; Green SM; Vedeckis W
Oncogene; 1989 Jun; 4(6):773-87. PubMed ID: 2660073
[TBL] [Abstract][Full Text] [Related]
34. Induction of ornithine decarboxylase by IL-3 is mediated by sequential c-Myc-independent and c-Myc-dependent pathways.
Packham G; Cleveland JL
Oncogene; 1997 Sep; 15(10):1219-32. PubMed ID: 9294616
[TBL] [Abstract][Full Text] [Related]
35. Efficient induction of focus formation in a subclone of NIH3T3 cells by c-myc and its inhibition by serum and by growth factors.
Blondel B; Talbot N; Merlo GR; Wychowski C; Yokozaki H; Valverius EM; Salomon DS; Bassin RH
Oncogene; 1990 Jun; 5(6):857-65. PubMed ID: 2193293
[TBL] [Abstract][Full Text] [Related]
36. Constitutive versus cell cycle regulation of c-myb mRNA expression correlates with developmental stages in murine B lymphoid tumors.
Catron KM; Purkerson JM; Isakson PC; Bender TP
J Immunol; 1992 Feb; 148(3):934-42. PubMed ID: 1730880
[TBL] [Abstract][Full Text] [Related]
37. The expression and regulation of c-myb transcription in B6/lpr Lyt-2-, L3T4-T lymphocytes.
Yokota S; Yuan D; Katagiri T; Eisenberg RA; Cohen PL; Ting JP
J Immunol; 1987 Oct; 139(8):2810-7. PubMed ID: 3116095
[TBL] [Abstract][Full Text] [Related]
38. Transformation of T lymphocytes by the v-fos oncogene.
Valge-Archer VE; de Villiers J; Sinskey AJ; Rao A
J Immunol; 1990 Dec; 145(12):4355-64. PubMed ID: 2124241
[TBL] [Abstract][Full Text] [Related]
39. Cyclic AMP-mediated suppression of normal and neoplastic B cell proliferation is associated with regulation of myc and Ha-ras protooncogenes.
Blomhoff HK; Smeland EB; Beiske K; Blomhoff R; Ruud E; Bjøro T; Pfeifer-Ohlsson S; Watt R; Funderud S; Godal T
J Cell Physiol; 1987 Jun; 131(3):426-33. PubMed ID: 3036888
[TBL] [Abstract][Full Text] [Related]
40. Oncogenes with potential nuclear function: myc, myb and fos.
Eisenman RN; Thompson CB
Cancer Surv; 1986; 5(2):309-27. PubMed ID: 3779660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]